1. Home
  2. LBPH vs LVWR Comparison

LBPH vs LVWR Comparison

Compare LBPH & LVWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBPH
  • LVWR
  • Stock Information
  • Founded
  • LBPH 2020
  • LVWR 2022
  • Country
  • LBPH United States
  • LVWR United States
  • Employees
  • LBPH N/A
  • LVWR 248
  • Industry
  • LBPH Biotechnology: Pharmaceutical Preparations
  • LVWR
  • Sector
  • LBPH Health Care
  • LVWR
  • Exchange
  • LBPH Nasdaq
  • LVWR Nasdaq
  • Market Cap
  • LBPH 1.4B
  • LVWR 1.3B
  • IPO Year
  • LBPH 2021
  • LVWR N/A
  • Fundamental
  • Price
  • LBPH $59.81
  • LVWR $6.52
  • Analyst Decision
  • LBPH Buy
  • LVWR Hold
  • Analyst Count
  • LBPH 8
  • LVWR 1
  • Target Price
  • LBPH $52.29
  • LVWR $7.25
  • AVG Volume (30 Days)
  • LBPH 834.8K
  • LVWR 21.3K
  • Earning Date
  • LBPH 11-07-2024
  • LVWR 10-24-2024
  • Dividend Yield
  • LBPH N/A
  • LVWR N/A
  • EPS Growth
  • LBPH N/A
  • LVWR N/A
  • EPS
  • LBPH N/A
  • LVWR N/A
  • Revenue
  • LBPH N/A
  • LVWR $30,963,000.00
  • Revenue This Year
  • LBPH N/A
  • LVWR $3.44
  • Revenue Next Year
  • LBPH N/A
  • LVWR $136.41
  • P/E Ratio
  • LBPH N/A
  • LVWR N/A
  • Revenue Growth
  • LBPH N/A
  • LVWR N/A
  • 52 Week Low
  • LBPH $3.60
  • LVWR $5.20
  • 52 Week High
  • LBPH $59.95
  • LVWR $12.04
  • Technical
  • Relative Strength Index (RSI)
  • LBPH 78.81
  • LVWR 56.29
  • Support Level
  • LBPH $59.47
  • LVWR $5.96
  • Resistance Level
  • LBPH $59.85
  • LVWR $6.69
  • Average True Range (ATR)
  • LBPH 0.20
  • LVWR 0.40
  • MACD
  • LBPH -0.84
  • LVWR 0.01
  • Stochastic Oscillator
  • LBPH 86.36
  • LVWR 50.34

About LBPH Longboard Pharmaceuticals Inc.

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies.

About LVWR LiveWire Group Inc.

LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel.

Share on Social Networks: